Quick answers
- What is Diprivan?
- Diprivan is a brand name of Propofol, a prescription medicine. The FDA NDC Directory lists 2 Diprivan products in 1 strength and form.
- Who makes Diprivan?
- Fresenius Kabi USA holds the FDA application for Diprivan (NDA019627, approved October 2, 1989).
- Is there a generic or store brand of Diprivan?
- Yes. The FDA NDC Directory lists 33 other products with the same active ingredients, strength and form as a Diprivan product, 33 of them generic. Ask your pharmacist whether one is right for you.
- Has Diprivan been recalled?
- FDA enforcement reports list 2 recalls of Diprivan products; the newest started April 13, 2022. A recall usually concerns specific lots, not every product.
What Diprivan is
Each Diprivan product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Propofol · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| propofol 10 mg/mL injection, emulsion (intravenous) | Diprivan | 33 products, 13 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Propofol →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA019627 | Fresenius Kabi USA | October 2, 1989 | 2 |
Companies that list Diprivan
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Diprivan products.
- Fresenius Kabi USA, LLC2 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
April 13, 2022 · Class II · Terminated · D-1116-2022
cGMP deviations: Temperature abuse
Diprivan (Propofol) Emulsion, 200 mg per 20 mL (10mg/mL), 20 mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-29 — Mckesson Medical-Surgical Inc. Corporate Office
-
April 13, 2022 · Class II · Terminated · D-1115-2022
cGMP deviations: Temperature abuse
Diprivan (Propofol) Emulsion, 100 mg/mL, 10mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-10 — Mckesson Medical-Surgical Inc. Corporate Office
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.